Cargando…
Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use
Tropisetron is an adjuvant for butorphanol used in intravenous patient-controlled analgesia (PCA) and has been reported to provide superior pain control. It is efficacious in reducing the incidence of postoperative nausea and vomiting. However, this admixture is not available commercially and stabil...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602760/ https://www.ncbi.nlm.nih.gov/pubmed/25674732 http://dx.doi.org/10.1097/MD.0000000000000432 |
_version_ | 1782394785784397824 |
---|---|
author | Chen, Fu-Chao Shi, Xiao-Ya Li, Peng Yang, Jin-Guo Zhou, Ben-Hong |
author_facet | Chen, Fu-Chao Shi, Xiao-Ya Li, Peng Yang, Jin-Guo Zhou, Ben-Hong |
author_sort | Chen, Fu-Chao |
collection | PubMed |
description | Tropisetron is an adjuvant for butorphanol used in intravenous patient-controlled analgesia (PCA) and has been reported to provide superior pain control. It is efficacious in reducing the incidence of postoperative nausea and vomiting. However, this admixture is not available commercially and stability data applicable to hospital practice are limited. This study aimed to describe the drug compounding and evaluates the long-term (up to 14 days) stability of butorphanol and tropisetron in 0.9% sodium chloride injection for PCA use. In this study, commercial solutions of butorphanol tartrate and tropisetron hydrochloride were combined and further diluted with 0.9% sodium chloride injection to final concentrations of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL. The polyolefin bags and glass bottles were stored at 4°C and 25°C for up to 14 days. The drug stabilities were determined by visual inspection, pH measurement, and high-pressure liquid chromatography assay of drug concentrations. The data obtained for admixtures prepared and stored at temperatures of 25°C and 4°C show the drugs have maintained at least 98% of the initial concentration. All solutions remained clear and colorless over the 14-day period, and the pH value did not change significantly. The results indicate that admixtures of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL in 0.9% sodium chloride injection solution were stable for 14 days when stored in polyolefin bags or glass bottles at 4°C and 25°C and protected from light. The infusion is feasible for manufacturing in pharmacy aseptic units and can be stored for up to 14 days for routine use in PCA infusions. |
format | Online Article Text |
id | pubmed-4602760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46027602015-10-27 Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use Chen, Fu-Chao Shi, Xiao-Ya Li, Peng Yang, Jin-Guo Zhou, Ben-Hong Medicine (Baltimore) 3300 Tropisetron is an adjuvant for butorphanol used in intravenous patient-controlled analgesia (PCA) and has been reported to provide superior pain control. It is efficacious in reducing the incidence of postoperative nausea and vomiting. However, this admixture is not available commercially and stability data applicable to hospital practice are limited. This study aimed to describe the drug compounding and evaluates the long-term (up to 14 days) stability of butorphanol and tropisetron in 0.9% sodium chloride injection for PCA use. In this study, commercial solutions of butorphanol tartrate and tropisetron hydrochloride were combined and further diluted with 0.9% sodium chloride injection to final concentrations of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL. The polyolefin bags and glass bottles were stored at 4°C and 25°C for up to 14 days. The drug stabilities were determined by visual inspection, pH measurement, and high-pressure liquid chromatography assay of drug concentrations. The data obtained for admixtures prepared and stored at temperatures of 25°C and 4°C show the drugs have maintained at least 98% of the initial concentration. All solutions remained clear and colorless over the 14-day period, and the pH value did not change significantly. The results indicate that admixtures of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL in 0.9% sodium chloride injection solution were stable for 14 days when stored in polyolefin bags or glass bottles at 4°C and 25°C and protected from light. The infusion is feasible for manufacturing in pharmacy aseptic units and can be stored for up to 14 days for routine use in PCA infusions. Wolters Kluwer Health 2015-02-13 /pmc/articles/PMC4602760/ /pubmed/25674732 http://dx.doi.org/10.1097/MD.0000000000000432 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 3300 Chen, Fu-Chao Shi, Xiao-Ya Li, Peng Yang, Jin-Guo Zhou, Ben-Hong Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title | Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title_full | Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title_fullStr | Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title_full_unstemmed | Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title_short | Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use |
title_sort | stability of butorphanol–tropisetron mixtures in 0.9% sodium chloride injection for patient-controlled analgesia use |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602760/ https://www.ncbi.nlm.nih.gov/pubmed/25674732 http://dx.doi.org/10.1097/MD.0000000000000432 |
work_keys_str_mv | AT chenfuchao stabilityofbutorphanoltropisetronmixturesin09sodiumchlorideinjectionforpatientcontrolledanalgesiause AT shixiaoya stabilityofbutorphanoltropisetronmixturesin09sodiumchlorideinjectionforpatientcontrolledanalgesiause AT lipeng stabilityofbutorphanoltropisetronmixturesin09sodiumchlorideinjectionforpatientcontrolledanalgesiause AT yangjinguo stabilityofbutorphanoltropisetronmixturesin09sodiumchlorideinjectionforpatientcontrolledanalgesiause AT zhoubenhong stabilityofbutorphanoltropisetronmixturesin09sodiumchlorideinjectionforpatientcontrolledanalgesiause |